Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease

Francisco A Uzal, John C. Freedman, Archana Shrestha, James R. Theoret, Jorge Garcia, Milena M. Awad, Vicki Adams, Robert J. Moore, Julian I. Rood, Bruce A. Mcclane

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Clostridium perfringens uses its arsenal of >16 toxins to cause histotoxic and intestinal infections in humans and animals. It has been unclear why this bacterium produces so many different toxins, especially since many target the plasma membrane of host cells. However, it is now established that C. perfringens uses chromosomally encoded alpha toxin (a phospholipase C) and perfringolysin O (a pore-forming toxin) during histotoxic infections. In contrast, this bacterium causes intestinal disease by employing toxins encoded by mobile genetic elements, including C. perfringens enterotoxin, necrotic enteritis toxin B-like, epsilon toxin and beta toxin. Like perfringolysin O, the toxins with established roles in intestinal disease form membrane pores. However, the intestinal disease-associated toxins vary in their target specificity, when they are produced (sporulation vs vegetative growth), and in their sensitivity to intestinal proteases. Producing many toxins with diverse characteristics likely imparts virulence flexibility to C. perfringens so it can cause an array of diseases.

Original languageEnglish (US)
Pages (from-to)361-377
Number of pages17
JournalFuture Microbiology
Volume9
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Intestinal Diseases
Animal Diseases
Clostridium perfringens
Interspersed Repetitive Sequences
Bacteria
Enteritis
Type C Phospholipases
Infection
Virulence
Peptide Hydrolases
Cell Membrane
Membranes
Growth
Clostridium perfringens theta-toxin

Keywords

  • animal disease
  • avian necrotic enteritis
  • Clostridium perfringens
  • enterocolitis
  • enterotoxemia
  • food poisoning
  • gas gangrene
  • human disease
  • toxins

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Uzal, F. A., Freedman, J. C., Shrestha, A., Theoret, J. R., Garcia, J., Awad, M. M., ... Mcclane, B. A. (2014). Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiology, 9(3), 361-377. https://doi.org/10.2217/fmb.13.168

Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. / Uzal, Francisco A; Freedman, John C.; Shrestha, Archana; Theoret, James R.; Garcia, Jorge; Awad, Milena M.; Adams, Vicki; Moore, Robert J.; Rood, Julian I.; Mcclane, Bruce A.

In: Future Microbiology, Vol. 9, No. 3, 2014, p. 361-377.

Research output: Contribution to journalArticle

Uzal, FA, Freedman, JC, Shrestha, A, Theoret, JR, Garcia, J, Awad, MM, Adams, V, Moore, RJ, Rood, JI & Mcclane, BA 2014, 'Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease', Future Microbiology, vol. 9, no. 3, pp. 361-377. https://doi.org/10.2217/fmb.13.168
Uzal, Francisco A ; Freedman, John C. ; Shrestha, Archana ; Theoret, James R. ; Garcia, Jorge ; Awad, Milena M. ; Adams, Vicki ; Moore, Robert J. ; Rood, Julian I. ; Mcclane, Bruce A. / Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. In: Future Microbiology. 2014 ; Vol. 9, No. 3. pp. 361-377.
@article{a2014603b3d448dcafc4cbcb1c817786,
title = "Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease",
abstract = "Clostridium perfringens uses its arsenal of >16 toxins to cause histotoxic and intestinal infections in humans and animals. It has been unclear why this bacterium produces so many different toxins, especially since many target the plasma membrane of host cells. However, it is now established that C. perfringens uses chromosomally encoded alpha toxin (a phospholipase C) and perfringolysin O (a pore-forming toxin) during histotoxic infections. In contrast, this bacterium causes intestinal disease by employing toxins encoded by mobile genetic elements, including C. perfringens enterotoxin, necrotic enteritis toxin B-like, epsilon toxin and beta toxin. Like perfringolysin O, the toxins with established roles in intestinal disease form membrane pores. However, the intestinal disease-associated toxins vary in their target specificity, when they are produced (sporulation vs vegetative growth), and in their sensitivity to intestinal proteases. Producing many toxins with diverse characteristics likely imparts virulence flexibility to C. perfringens so it can cause an array of diseases.",
keywords = "animal disease, avian necrotic enteritis, Clostridium perfringens, enterocolitis, enterotoxemia, food poisoning, gas gangrene, human disease, toxins",
author = "Uzal, {Francisco A} and Freedman, {John C.} and Archana Shrestha and Theoret, {James R.} and Jorge Garcia and Awad, {Milena M.} and Vicki Adams and Moore, {Robert J.} and Rood, {Julian I.} and Mcclane, {Bruce A.}",
year = "2014",
doi = "10.2217/fmb.13.168",
language = "English (US)",
volume = "9",
pages = "361--377",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease

AU - Uzal, Francisco A

AU - Freedman, John C.

AU - Shrestha, Archana

AU - Theoret, James R.

AU - Garcia, Jorge

AU - Awad, Milena M.

AU - Adams, Vicki

AU - Moore, Robert J.

AU - Rood, Julian I.

AU - Mcclane, Bruce A.

PY - 2014

Y1 - 2014

N2 - Clostridium perfringens uses its arsenal of >16 toxins to cause histotoxic and intestinal infections in humans and animals. It has been unclear why this bacterium produces so many different toxins, especially since many target the plasma membrane of host cells. However, it is now established that C. perfringens uses chromosomally encoded alpha toxin (a phospholipase C) and perfringolysin O (a pore-forming toxin) during histotoxic infections. In contrast, this bacterium causes intestinal disease by employing toxins encoded by mobile genetic elements, including C. perfringens enterotoxin, necrotic enteritis toxin B-like, epsilon toxin and beta toxin. Like perfringolysin O, the toxins with established roles in intestinal disease form membrane pores. However, the intestinal disease-associated toxins vary in their target specificity, when they are produced (sporulation vs vegetative growth), and in their sensitivity to intestinal proteases. Producing many toxins with diverse characteristics likely imparts virulence flexibility to C. perfringens so it can cause an array of diseases.

AB - Clostridium perfringens uses its arsenal of >16 toxins to cause histotoxic and intestinal infections in humans and animals. It has been unclear why this bacterium produces so many different toxins, especially since many target the plasma membrane of host cells. However, it is now established that C. perfringens uses chromosomally encoded alpha toxin (a phospholipase C) and perfringolysin O (a pore-forming toxin) during histotoxic infections. In contrast, this bacterium causes intestinal disease by employing toxins encoded by mobile genetic elements, including C. perfringens enterotoxin, necrotic enteritis toxin B-like, epsilon toxin and beta toxin. Like perfringolysin O, the toxins with established roles in intestinal disease form membrane pores. However, the intestinal disease-associated toxins vary in their target specificity, when they are produced (sporulation vs vegetative growth), and in their sensitivity to intestinal proteases. Producing many toxins with diverse characteristics likely imparts virulence flexibility to C. perfringens so it can cause an array of diseases.

KW - animal disease

KW - avian necrotic enteritis

KW - Clostridium perfringens

KW - enterocolitis

KW - enterotoxemia

KW - food poisoning

KW - gas gangrene

KW - human disease

KW - toxins

UR - http://www.scopus.com/inward/record.url?scp=84899497705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899497705&partnerID=8YFLogxK

U2 - 10.2217/fmb.13.168

DO - 10.2217/fmb.13.168

M3 - Article

VL - 9

SP - 361

EP - 377

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 3

ER -